Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Mirata 150mg


Contraindicated
Embryolethality

Contraindicated
Mirata 150mg :
Type Medicine Authorised
Originator Tarceva 150mg
Agent Droguerie Mercury
Distributor Droguerie Mercury
Laboratory Hikma Pharmaceuticals
Responsible Party Hikma Pharmaceuticals
Origin Jordan
Manufacturer The Arab Pharmaceutical Manufacturing Co Ltd
Manufacturing Type G
Origin Jordan
ATC L01XE03

Your comment will appear shortly after approval

Mirata 150mg :

Revision Date : 01/01/2012


Effect Frequency
Abdominal pain Very Common
Acne Common
Alopecia Very Common
ALT increased Common
Anorexia Very Common
AST increased Common
Blistering Common
Blood bilirubin increased Common
Brittle nails Common
Bullous disorder Not known
Cephalea Very Common
Conjunctivitis Very Common
Corneal perforation Very rare
Corneal ulcer Very rare
Cough Very Common
Depression Very Common
Dermatitis acneiform Common
Diarrhoea (Diarrhea) Very Common
Dry skin Very Common
Dyspepsia Very Common
Dyspnoea (dyspnea) Very Common
Epistaxis (Nasal bleeding) Common
Exfoliative skin conditions Not known
Eyebrow changes Common
Eyelash changes Common
Eyelash thickening Common
Fatigue Very Common
Flatulence Very Common
Folliculitis Common
Gastrointestinal bleeding Common
Gastrointestinal perforation Uncommon
Growth of eyelashes Common
Growth of eyelashes abnormal Common
Hair changes Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Rare
Hirsutism Common
Infection Very Common
Ingrowing eyelashes Common
Interstitial pneumonitis Uncommon
Keratitis Common
Keratoconjunctivitis sicca Very Common
Loose nails Common
Lyell Syndrome (Toxic epidermal necrolysis) Very rare
Nail disorders Common
Nausea Very Common
Neuropathy Very Common
Paronychia Common
Pruritus Very Common
Pyrexia Very Common
Rigors Very Common
Skin Eruption Very Common
Skin fissures Common
Skin hyperpigmentation Uncommon
Stevens-Johnson syndrome Very rare
Stomatitis Very Common
Vomiting Very Common
Weight decreased (Weight loss) Very Common

Different Units By MoH Code

Mirata 150mg  MoH 10032 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 30
Strength 150mg
Storage Condition <30°C In the original container
Public Price 1455261 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 112916/1
Submission date 08/11/2016
Registration Year 24/10/2019
Pending Year 07/05/2019
Pending Reason Incomplete file


Price Comparison

● Country: Jordan
● Package Size: 30
● Public Price: 1233.63 JOD ( 154,476,382.23 LBP )
● Pack size unit used: 30
● Cost/Unit: 41,121 JOD ( 5,134,061.00 LBP )
● Pharmacy Price: 1186.18 JOD ( 148534645.78 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 30
● Public Price: 583.86 BHD ( 138,803,373.24 LBP )
● Pack size unit used: 30
● Cost/Unit: 19,462 BHD ( 4,516,946.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 30
● Public Price: 4986.85 SAR ( 117,889,134.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 166,2283 SAR ( 3,924,240.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet, Film-Coated
● Package Size: Box of 30
● Public Price: 1455261 LBP ( 1,455,261.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 48508,7 LBP ( 48,508.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info